Patent · US Expired

Antitumor agents LL-D49194.alpha..sub.1, LL-D49194.beta..sub.1, LL-D49194.beta..sub.2, LL-D49194.beta..sub.3, LL-D49194.gamma., LL-D49194.delta., LL-D49194.epsilon., LL-D49194.xi., LL-D49194.eta., LL-D49194.omega..sub.1, LL-D49194.omega..sub.2, and LL-D49194.omega..sub.3

US4626503A · kind A · utility

6Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 1985
Grant dateDec 2, 1986
Priority date—
Expiry dateFeb 14, 2005

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/465
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Antitumor agents LL-D49194.alpha..sub.1, LL-D49194.beta..sub.1, LL-D49194.beta..sub.2, LL-D49194.beta..sub.3, LL-D49194.gamma., LL-D49194.delta., LL-D49194.epsilon., LL-D49194.xi., LL-D49194.eta., LL-D49194.omega., LL-D49194.omega..sub.2 and LL-D49194.omega..sub.3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.